Drug treatment of elevated blood pressure

Australian Prescriber

Volumn 33, Issue 4, 2010, Pages 108-112

  Nelson, Mark ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Antihypertensives; Cardiovascular disease; Hypertension

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; DIHYDROPYRIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METOPROLOL; PINDOLOL; POTASSIUM SPARING DIURETIC AGENT; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; VERAPAMIL;

ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; COMORBIDITY; DIASTOLIC BLOOD PRESSURE; DRUG ANTAGONISM; DRUG CHOICE; DRUG COST; DRUG EFFICACY; DRUG SAFETY; HEART INFARCTION; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MEDICAL DECISION MAKING; STROKE; SYSTOLIC BLOOD PRESSURE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

EID: 77957071472     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2010.055     Document Type: Article

References (11)

1. Huang N, Duggan K, Harman J. Lifestyle management of hypertension. Aust Prescr 2008;31:150-3.
2. National Heart Foundation of Australia (National Blood Pressure and Vascular Disease Advisory Committee). Guide to management of hypertension 2008. Updated 2009 Aug. www.heartfoundation.org.au/SiteCollectionDocuments/A_ Hypert_Guidelines2008_2009Update_FINAL.pdf [cited 2010 Jul 7]
3. National Vascular Disease Prevention Alliance. Guidelines for the assessment of absolute cardiovascular disease risk. 2009. www.heartfoundation.org.au/SiteCollectionDocuments/A_AR_ Guidelines_FINAL%20FOR%20WEB.pdf [cited 2010 Jul 7]
4. Wang Z, Hoy WE. Is the Framingham coronary heart disease absolute risk function applicable to Aboriginal people? Med J Aust 2005;182:66-9.
5. Australian cardiovascular risk charts. In: Absolute cardiovascular disease risk assessment - quick reference guide for health professionals. National Heart Foundation of Australia. 2009. www.heartfoundation.org.au/SiteCollectionDocuments/A_ AR_RiskCharts_FINAL%20FOR%20WEB.pdf [cited 2010 Jul 7]
6. Australian absolute cardiovascular disease risk calculator. National Stroke Foundation. 2009. www.cvdcheck.org.au [cited 2010 Jul 7]
7. Lindholm LH, Carlberg B, Samuelsson O. Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet 2005;366:1545-53.
8. Bangalore S, Parkar S, Grossman E, Messerli FH. A metaanalysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus. Am J Cardiol 2007;100:1254-62.
9. Kjeldsen SE, Jamerson KA, Bakris GL, Pitt B, Dahlöf B, Velazquez EJ, et al. Avoiding Cardiovascular events through COMbination therapy in Patients LIving with Systolic Hypertension Investigators. Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: the ACCOMPLISH study. Blood Press 2008;17:7-17.
10. Nelson MR, Reid CM, Krum H, Muir T, Ryan P, McNeil JJ. Predictors of normotension on withdrawal of antihypertensive drugs in elderly patients: prospective study in second Australian national blood pressure study cohort. BMJ 2002;325:815-7.
11. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al; HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008;358:1887-98.